Published in Exp Dermatol on March 23, 2010
Thermographical measuring of the skin temperature using laser needle acupuncture in preterm neonates. Evid Based Complement Alternat Med (2012) 0.94
The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention. Clin Dev Immunol (2013) 0.93
The infant skin barrier: can we preserve, protect, and enhance the barrier? Dermatol Res Pract (2012) 0.82
Skin Physiology of the Neonate and Infant: Clinical Implications. Adv Wound Care (New Rochelle) (2015) 0.80
Potential NICU Environmental Influences on the Neonate's Microbiome: A Systematic Review. Adv Neonatal Care (2015) 0.79
Transdermal patches: history, development and pharmacology. Br J Pharmacol (2015) 0.78
Skin microbiome before development of atopic dermatitis: Early colonization with commensal staphylococci at 2 months is associated with a lower risk of atopic dermatitis at 1 year. J Allergy Clin Immunol (2016) 0.77
Tolerance of skin care regimen in healthy, full-term neonates. Clin Cosmet Investig Dermatol (2013) 0.76
Prognosis of full-thickness skin defects in premature infants. Arch Plast Surg (2012) 0.75
Infant skin maturation: Preliminary outcomes for color and biomechanical properties. Skin Res Technol (2017) 0.75
Caspase-14 protects against epidermal UVB photodamage and water loss. Nat Cell Biol (2007) 2.82
Cyclobutane pyrimidine dimers are predominant DNA lesions in whole human skin exposed to UVA radiation. Proc Natl Acad Sci U S A (2006) 2.19
The cost effectiveness of biologic therapy for the treatment of chronic plaque psoriasis in real practice settings in Italy. BioDrugs (2014) 1.99
A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa. J Invest Dermatol (2010) 1.61
Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): a retrospective case series of 19 patients. J Am Acad Dermatol (2011) 1.48
Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities. J Invest Dermatol (2003) 1.47
SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels. J Invest Dermatol (2005) 1.41
Filaggrin genotype in ichthyosis vulgaris predicts abnormalities in epidermal structure and function. Am J Pathol (2011) 1.41
Recall dermatitis after systemic treatment with paclitaxel. Int J Dermatol (2010) 1.37
Clinical implications of aging skin: cutaneous disorders in the elderly. Am J Clin Dermatol (2009) 1.26
Structural and functional consequences of loricrin mutations in human loricrin keratoderma (Vohwinkel syndrome with ichthyosis). J Invest Dermatol (2004) 1.24
Acute modulations in permeability barrier function regulate epidermal cornification: role of caspase-14 and the protease-activated receptor type 2. Am J Pathol (2007) 1.20
RhoB protects human keratinocytes from UVB-induced apoptosis through epidermal growth factor receptor signaling. J Biol Chem (2005) 1.16
Repair of the three main types of bipyrimidine DNA photoproducts in human keratinocytes exposed to UVB and UVA radiations. DNA Repair (Amst) (2005) 1.14
pH-regulated mechanisms account for pigment-type differences in epidermal barrier function. J Invest Dermatol (2009) 1.13
Basis for abnormal desquamation and permeability barrier dysfunction in RXLI. J Invest Dermatol (2004) 1.12
Phenotypic characterization of osteoblasts from the sclerotic zones of osteoarthritic subchondral bone. Arthritis Rheum (2008) 1.09
Functional consequences of a neutral pH in neonatal rat stratum corneum. J Invest Dermatol (2004) 1.09
Treatment of generalized vitiligo with anti-TNF-α Agents. J Drugs Dermatol (2012) 1.08
Psychosocial and societal burden of incontinence in the aged population: a review. Arch Gynecol Obstet (2007) 1.06
Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections. J Clin Invest (2012) 1.00
In vivo and in vitro evidence of dermal fibroblasts influence on human epidermal pigmentation. Pigment Cell Res (2006) 0.95
Molecular diagnosis of oculocutaneous albinism: new mutations in the OCA1-4 genes and practical aspects. Pigment Cell Melanoma Res (2008) 0.95
Caspase-14-deficient mice are more prone to the development of parakeratosis. J Invest Dermatol (2012) 0.94
Larger yield of cyclobutane dimers than 8-oxo-7,8-dihydroguanine in the DNA of UVA-irradiated human skin cells. Mutat Res (2004) 0.94
Protective effects of total fraction of avocado/soybean unsaponifiables on the structural changes in experimental dog osteoarthritis: inhibition of nitric oxide synthase and matrix metalloproteinase-13. Arthritis Res Ther (2009) 0.91
A novel mutation in the fatty acid transport protein 4 gene in a patient initially described as affected by self-healing congenital verruciform hyperkeratosis. Am J Med Genet A (2010) 0.91
Avocado/soybean unsaponifiables increase aggrecan synthesis and reduce catabolic and proinflammatory mediator production by human osteoarthritic chondrocytes. J Rheumatol (2003) 0.91
Regulation of subchondral bone osteoblast metabolism by cyclic compression. Arthritis Rheum (2011) 0.90
Developing core outcome set for vitiligo clinical trials: international e-Delphi consensus. Pigment Cell Melanoma Res (2015) 0.89
Emollients, moisturizers, and keratolytic agents in psoriasis. Clin Dermatol (2008) 0.88
UVA induces granzyme B in human keratinocytes through MIF: implication in extracellular matrix remodeling. J Biol Chem (2007) 0.88
Effective therapy with anti-TNF-alpha in patients with psoriatic arthritis is associated with decreased levels of metalloproteinases and angiogenic cytokines in the sera and skin lesions. Ann N Y Acad Sci (2007) 0.88
Incontinence in the aged: contact dermatitis and other cutaneous consequences. Contact Dermatitis (2007) 0.88
Beyond vitiligo guidelines: combined stratified/personalized approaches for the vitiligo patient. Exp Dermatol (2014) 0.87
[Bullous pemphigoid, primary biliary cirrhosis and vitiligo: a multiple autoimmune syndrome?]. Ann Med Interne (Paris) (2002) 0.87
Proteolytically active allergens cause barrier breakdown. J Invest Dermatol (2008) 0.87
Cannabinoid receptors 1 and 2 oppositely regulate epidermal permeability barrier status and differentiation. Exp Dermatol (2012) 0.86
Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha. J Autoimmune Dis (2006) 0.86
Toll-like receptor 2 activation by lipoteichoic acid induces differential production of pro-inflammatory cytokines in human odontoblasts, dental pulp fibroblasts and immature dendritic cells. Immunobiology (2009) 0.86
Unrepaired cyclobutane pyrimidine dimers do not prevent proliferation of UV-B-irradiated cultured human fibroblasts. Photochem Photobiol (2004) 0.86
Human keratinocytes acquire cellular cytotoxicity under UV-B irradiation. Implication of granzyme B and perforin. J Biol Chem (2006) 0.86
Type I interferon signature in the initiation of the immune response in vitiligo. Pigment Cell Melanoma Res (2014) 0.86
Incidence of psoriasis and association with comorbidities in Italy: a 5-year observational study from a national primary care database. Eur J Dermatol (2010) 0.86
Odontoblast control of dental pulp inflammation triggered by cariogenic bacteria. Front Physiol (2013) 0.85
The lymphoid variant of hypereosinophilic syndrome: study of 21 patients with CD3-CD4+ aberrant T-cell phenotype. Medicine (Baltimore) (2014) 0.85
Cytokine production by human odontoblast-like cells upon Toll-like receptor-2 engagement. Immunobiology (2010) 0.85
Percutaneous cryoablation of symptomatic localized venous malformations: preliminary short-term results. J Vasc Interv Radiol (2013) 0.84
Follicular vitiligo: a new form of vitiligo. Pigment Cell Melanoma Res (2012) 0.84
Age-related differences in sensitivity of peripheral blood monocytes to lipopolysaccharide and Staphylococcus aureus toxin B in atopic dermatitis. J Invest Dermatol (2007) 0.84
Expression of NOD2 is increased in inflamed human dental pulps and lipoteichoic acid-stimulated odontoblast-like cells. Innate Immun (2009) 0.84
Cost-effectiveness analysis of TNF-alpha blockers for the treatment of chronic plaque psoriasis in the perspective of the Italian health-care system. Dermatol Ther (2010) 0.84
The "caveolae brake hypothesis" and the epidermal barrier. J Invest Dermatol (2008) 0.83
Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis. Immunopharmacol Immunotoxicol (2012) 0.83
Avocado/soybean unsaponifiables prevent the inhibitory effect of osteoarthritic subchondral osteoblasts on aggrecan and type II collagen synthesis by chondrocytes. J Rheumatol (2006) 0.83
Hematoma-like metastases. J Am Acad Dermatol (2006) 0.83
Koebner's phenomenon in vitiligo: European position paper. Pigment Cell Melanoma Res (2011) 0.83
Unilesional mycosis fungoides successfully treated with imiquimod. Eur J Dermatol (2006) 0.83
Lipopolysaccharide-binding protein inhibits toll-like receptor 2 activation by lipoteichoic acid in human odontoblast-like cells. J Endod (2013) 0.83
Topical peroxisome proliferator activated receptor activators accelerate postnatal stratum corneum acidification. J Invest Dermatol (2008) 0.83
Comparing in vivo reflectance confocal microscopy, dermoscopy, and histology of clear-cell acanthoma. Dermatol Surg (2009) 0.81
Neoplastic skin lesions in the elderly patient. Cutan Ocul Toxicol (2008) 0.81
Atypical protein kinase C stimulates nucleotide excision repair activity. FEBS Lett (2004) 0.81
Role of peroxisome proliferator-activated receptor alpha in epidermal development in utero. J Invest Dermatol (2002) 0.81
Topical application of preparations containing DNA repair enzymes prevents ultraviolet-induced telomere shortening and c-FOS proto-oncogene hyperexpression in human skin: an experimental pilot study. J Drugs Dermatol (2013) 0.81
Effects of AV119, a natural sugar from avocado, on Malassezia furfur invasiveness and on the expression of HBD-2 and cytokines in human keratinocytes. Exp Dermatol (2007) 0.80
New emollient with topical corticosteroid-sparing effect in treatment of childhood atopic dermatitis: SCORAD and quality of life improvement. Pediatr Dermatol (2008) 0.80
High resolution mapping of OCA2 intragenic rearrangements and identification of a founder effect associated with a deletion in Polish albino patients. Hum Genet (2010) 0.80
In vitro research on vitiligo: strategies, principles, methodological options and common pitfalls. Exp Dermatol (2012) 0.80
Study of CCN3 (NOV) and DDR1 in normal melanocytes and vitiligo skin. Exp Dermatol (2012) 0.80
Cole Disease Results from Mutations in ENPP1. Am J Hum Genet (2013) 0.80
Cutaneous hyphomycosis due to Paecilomyces lilacinus. Acta Derm Venereol (2012) 0.80
Evaluation of allergic vesicular reaction to patch test using in vivo confocal microscopy. Skin Res Technol (2011) 0.80
The benefits of sunflower oleodistillate (SOD) in pediatric dermatology. Pediatr Dermatol (2010) 0.79
Latent class analysis of a series of 717 patients with vitiligo allows the identification of two clinical subtypes. Pigment Cell Melanoma Res (2013) 0.79
Daily treatment with adapalene gel 0.1% maintains initial improvement of acne vulgaris previously treated with oral lymecycline. Eur J Dermatol (2007) 0.79
Neoadjuvant polychemotherapy in locally advanced Merkel cell carcinoma. Nat Rev Clin Oncol (2009) 0.79
Detection of an intragenic deletion expands the spectrum of CTSC mutations in Papillon-Lefèvre syndrome. J Invest Dermatol (2007) 0.79
Definition of Sensitive Skin: An Expert Position Paper from the Special Interest Group on Sensitive Skin of the International Forum for the Study of Itch. Acta Derm Venereol (2017) 0.78
The possible relevance of sex hormones on irritant and allergic responses: their importance for skin testing. Contact Dermatitis (2009) 0.78
Natural peroxisome proliferator-activated receptor-alpha agonist cream demonstrates similar therapeutic response to topical steroids in atopic dermatitis. J Dermatolog Treat (2010) 0.78
F 11782, a novel catalytic inhibitor of topoisomerases I and II, induces atypical, yet cytotoxic DNA double-strand breaks in CHO-K1 cells. Anticancer Res (2002) 0.78
Aquagenic syringeal acrokeratoderma. J Dtsch Dermatol Ges (2011) 0.78
Assessment of tyrosinase variants and skin cancer risk in a large cohort of French subjects. J Dermatol Sci (2011) 0.78
Halo nevi association in nonsegmental vitiligo affects age at onset and depigmentation pattern. Arch Dermatol (2012) 0.78
Aging skin and food supplements: the myth and the truth. Clin Dermatol (2008) 0.78
A double-blind, randomized, vehicle-controlled clinical study to evaluate the efficacy and safety of MAS063DP (ATOPICLAIR) in the management of atopic dermatitis in paediatric patients. Pediatr Allergy Immunol (2008) 0.78
Reflectance confocal microscopy of the yellow dot pattern in alopecia areata. Arch Dermatol (2011) 0.78
Development and validation of the K-VSCOR for scoring Koebner's phenomenon in vitiligo/non-segmental vitiligo. Pigment Cell Melanoma Res (2013) 0.78